FDA Authorizes Device to Quantify Psychedelics’ Effects on the BrainShutterstock.com

FDA Authorizes Cybin Device to Quantify Psychedelics’ Effects on the Brain

"This study of ketamine’s psychedelic effects while wearing headgear equipped with sensors to record brain activity could open up new frontiers of understanding," says Cybin's chief clinical officer.
Psychedelics Help Heal Childhood Trauma, Study FindsFGC / Shutterstock.com

Psychedelics Help Heal Childhood Trauma, Study Finds

Researchers find that there were significantly lower levels of complex trauma symptoms and feelings of internalized shame in study participants that had used psychedelics therapeutically.

Psilocybin Study for Tobacco Addiction Receives First Federal Psychedelics Research Grant in 50 Years

A Johns Hopkins Medicine professor says "it was only a matter of time," while lead researcher calls the historic grant "monumental" for the psychedelics movement.
Return Health Believes Psychedelics Can Treat Dementia

This New Company Believes Psychedelics Can Treat Dementia

There is currently no known cure for dementia, but Return Health CEO Dr. James Kuo says psychedelics offer "unprecedented" potential.
Psychedelic Use Associated with Reduced Risk of Heart Disease and Diabetes

Psychedelic Use Associated with Reduced Risk of Heart Disease and Diabetes

Researchers say there are several ways classic psychedelics could, directly and indirectly, lead to improved cardiometabolic health.
How Mindset Pharma Is Making and Defining 'Next-Generation Psychedelic Drugs'

How Mindset Pharma Is Making and Defining ‘Next-Generation Psychedelic Drugs’

CEO James Lanthier compares psychedelic medicines to aspirin, and explains why the company's lead candidate may be better than psilocybin.
World Boxing Association Partners with Psychedelics Company to Improve Brain Injury Treatment for Athletes

World Boxing Association Partners with Psychedelics Company for TBI and PTSD Research

"We believe in the promise of the resurgence of psychedelic medicine and are proud to be collaborating with Lobe Sciences as we work together to improve the lives and health of members of the WBA family," says WBA president Gilberto Jesús Mendoza.
86% of Oregon Adults Considering Psilocybin Are Interested in Microdosing

Vast Majority of Oregon Adults Interested in Psilocybin Want to Try Microdosing

On the flip side, 37% of Oregon adults surveyed said they did not know what psilocybin was.
Survey Shows American Psychologists Still Don't Really Understand Psychedelics

Survey Shows American Psychologists Still Don’t Really Understand Psychedelics

Less than half of psychologists surveyed agreed that psychedelics showed promise in the treatment of serious mental health issues.

Psyched Wellness to Study Amanita Muscaria Mushroom Extract for Sleep Disorders

Psychoactive compound muscimol has been shown to treat stress and anxiety, ease muscular pain, and promote restorative sleep.